|Articles|May 15, 2003

BioPharm International

  • BioPharm International-05-01-2003
  • Volume 16
  • Issue 5

Inside Washington: Medication Safety in the Limelight

Author(s)Jill Wechsler

by Jill Wechsler, BioPharm International FDA proposes bar codes on drug packages and new error reporting standards as part of its campaign to reduce medication errors.
To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

over 22 years ago

Demonstrating the Consistency of Small Data Sets: Application of the Weisberg t-test for Outliers

over 22 years ago

Sumeria to Satellites: Evolution of the Bioreactor

over 22 years ago

Patent Law: Extracting Maximum Value from Your Patent Portfolio

over 22 years ago

A Statistical Method to Account for Plate-to-Plate Variability in Multiple-Plate Bioassays

over 22 years ago

Part 11 Is Not Going Away: The New Electronic Records Draft Guidance

over 22 years ago

Survival Strategies: The Life Sciences Industry Turns to eLearning

over 22 years ago

Analytical Advances: Collaborative Effort Results in Automated Cell Culture System

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!